Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

Introduction Shigellosis is the second leading cause of diarrhoeal deaths among children worldwide. Oral azithromycin and intravenous ceftriaxone are the recommended first-line and second-line therapies for shigellosis in Bangladesh, respectively, but growing antibiotic resistance will require new a...

Full description

Saved in:
Bibliographic Details
Main Authors: Subhasish Das, Tahmeed Ahmed, Juliet Addo, Firdausi Qadri, Rachel Gibson, Patricia B Pavlinac, Md Jobayer Chisti, Farhana Khanam, Dilruba Ahmed, Sharika Nuzhat, Md Ridwan Islam, Syed Jayedul Bashar, Samuel L Arnold, Amy Newlands, Elena Fernandez Alvaro
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/2/e088449.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/15/2/e088449.full

Similar Items